Editorial: Sex and Gender Aspects in Diabetes.
作者信息
Kautzky-Willer Alexandra, von Euler Mia, Oertelt-Prigione Sabine
机构信息
Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Departments of Clinical Science and Education, Södersjukhuset and Medicine, Karolinska Institutet, Solna, Sweden.
出版信息
Front Endocrinol (Lausanne). 2019 Nov 26;10:813. doi: 10.3389/fendo.2019.00813. eCollection 2019.
Abstract
摘要
相似文献
1
Editorial: Sex and Gender Aspects in Diabetes.社论：糖尿病中的性别因素
Front Endocrinol (Lausanne). 2019 Nov 26;10:813. doi: 10.3389/fendo.2019.00813. eCollection 2019.
2
The Effect of Sex and Gender on Diabetic Complications.性别对糖尿病并发症的影响。
Curr Diabetes Rev. 2017;13(2):148-160. doi: 10.2174/1573399812666160517115756.
3
Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes.与糖尿病相关心血管并发症的性别相关治疗方法。
Pharmacol Res. 2017 May;119:195-207. doi: 10.1016/j.phrs.2017.01.023. Epub 2017 Feb 9.
4
[Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes].[关于糖尿病前期和糖尿病临床实践建议中的性别与性取向相关问题]
Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S151-8. doi: 10.1007/s00508-016-0957-1.
5
[Sex and gender-specific aspects in prediabetes and diabetes mellitus-clinical recommendations (Update 2019)].[糖尿病前期和糖尿病中的性别特异性方面——临床建议（2019年更新）]
Wien Klin Wochenschr. 2019 May;131(Suppl 1):221-228. doi: 10.1007/s00508-018-1421-1.
6
Sex-gender differences in diabetes vascular complications and treatment.糖尿病血管并发症及治疗中的性别差异。
Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):179-96. doi: 10.2174/187153012800493512.
7
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.2型糖尿病风险、病理生理学及并发症中的性别差异
Endocr Rev. 2016 Jun;37(3):278-316. doi: 10.1210/er.2015-1137. Epub 2016 May 9.
8
Sex and Gender Differences in Prevention of Type 2 Diabetes.2型糖尿病预防中的性别差异
Front Endocrinol (Lausanne). 2018 May 4;9:220. doi: 10.3389/fendo.2018.00220. eCollection 2018.
9
Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: a population based analysis from a Scottish region.社会经济地位和性别对 1 型和 2 型糖尿病患者血糖控制、心血管危险因素和糖尿病并发症的影响：苏格兰某地区的一项基于人群的分析。
Diabetes Metab. 2015 Apr;41(2):145-51. doi: 10.1016/j.diabet.2014.09.004. Epub 2014 Nov 14.
10
Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management.2型糖尿病中的性别差异：对心血管风险管理的影响。
Curr Pharm Des. 2017;23(10):1471-1476. doi: 10.2174/1381612823666170130153704.
引用本文的文献
1
Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease.重视性别在缺血性卒中及颈动脉粥样硬化性疾病中的作用。
Eur Heart J. 2022 Feb 10;43(6):460-473. doi: 10.1093/eurheartj/ehab756.
2
A Compendium of Perspectives on Diabetes: A Challenge for Sustainable Health in the Modern Era.《糖尿病观点汇编：现代时代可持续健康面临的挑战》
Diabetes Metab Syndr Obes. 2021 Jun 17;14:2775-2787. doi: 10.2147/DMSO.S304751. eCollection 2021.
本文引用的文献
1
Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology.全身治疗的疗效和毒性的性别差异：精准肿瘤学时代一个被低估的问题。
J Clin Oncol. 2018 Sep 10;36(26):2680-2683. doi: 10.1200/JCO.2018.78.3290. Epub 2018 Jul 13.
2
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.2型糖尿病风险、病理生理学及并发症中的性别差异
Endocr Rev. 2016 Jun;37(3):278-316. doi: 10.1210/er.2015-1137. Epub 2016 May 9.
3
A composite measure of gender and its association with risk factors in patients with premature acute coronary syndrome.性别综合指标及其与早发急性冠状动脉综合征患者危险因素的关联。
Psychosom Med. 2015 Jun;77(5):517-26. doi: 10.1097/PSY.0000000000000186.
4
Analysis of sex and gender-specific research reveals a common increase in publications and marked differences between disciplines.分析性别特异性研究揭示了出版物的普遍增加，以及学科之间的显著差异。
BMC Med. 2010 Nov 10;8:70. doi: 10.1186/1741-7015-8-70.
5
Sex differences in performance of fecal occult blood testing.粪便潜血检测的性别差异。
Am J Gastroenterol. 2010 Nov;105(11):2457-64. doi: 10.1038/ajg.2010.301. Epub 2010 Aug 10.
6
The Food and Drug Administration Office of Women's Health: impact of science on regulatory policy.美国食品药品监督管理局妇女健康办公室：科学对监管政策的影响
J Womens Health (Larchmt). 2007 Jul-Aug;16(6):807-17. doi: 10.1089/jwh.2006.0135.
Zotero 插件